Lv1
90 积分 2025-08-13 加入
Low serum complement C3 levels are associated with adverse clinical outcomes in myelodysplastic syndromes
1天前
已关闭
What do clinical trials teach us about the pathophysiology of human IgA nephropathy?
1天前
已完结
Targeting the alternative complement pathway by iptacopan abrogates C3 and strongly reduces C5b-9 deposition within glomeruli in IgA nephropathy recurrence after kidney transplantation
2天前
已完结
A Phase 2 Dose-Finding Trial of MY008211A in Complement Inhibitor-Naive Patients with Paroxysmal Nocturnal Hemoglobinuria and Signs of Active Hemolysis
15天前
已关闭
Complement Inhibition in Immunoglobulin A Nephropathy: A Mini-Review
21天前
已完结
The expanding role of complement inhibitors in the treatment of IgA nephropathy
22天前
已关闭
Treatment of transplantation-associated thrombotic microangiopathy with iptacopan: two cases report
22天前
已完结
High incidence of severe TA-TMA increases mortality in adult allogeneic transplant recipients: a prospective MIDAS Consortium study
22天前
已完结
Leveraging Model-Informed Drug Development to Predict Asciminib Efficacy in Second-Line Treatment of Chronic Myeloid Leukemia in Chronic Phase
30天前
已完结
Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design
1个月前
已完结
皖公网安备34019202002308
